Literature DB >> 12592253

Systemic administration of betamethasone delays endotoxin-induced preterm labor in the murine model.

William J Schwartz1, H Dix Christensen, J Chris Carey, William F Rayburn, Christina Gonzalez.   

Abstract

OBJECTIVE: The purpose of this study was to determine whether the administration of betamethasone decreases the endotoxin-induced preterm parturition rate and inhibits the risk of cytokines in the murine model. STUDY
DESIGN: Endotoxin was administered intraperitoneally at gestational day 15 (75% of gestation). In phase I, the duration of gestation was measured in 36 gravid C3H/HeOu mice that were equally divided into four treatment groups: control, endotoxin only, and two different dose regimens of betamethasone followed by endotoxin. In phase II, maternal serum and amniotic fluid concentrations of cytokines (interleukin-1alpha, tumor necrosis factor-alpha, and interleukin-6) were measured at 4 hours after endotoxin injection in 44 gravid mice divided equally in the four treatment groups.
RESULTS: The group that was exposed only to endotoxin was delivered at a significantly earlier gestational age compared with the control group (16.2 +/- 0.4 days vs 19.6 +/- 0.2 days; P <.01). The two groups that were pretreated with betamethasone before the endotoxin were delivered at gestational ages similar to the control group. There was a marked increase of tumor necrosis factor-alpha and interleukin-6 levels in amniotic fluid of mice that were treated with endotoxin only compared with the control group (P <.001). No difference in cytokine levels was found in those mice that were premedicated with betamethasone compared with the control group.
CONCLUSION: Antenatal administration of betamethasone to mice delayed preterm parturition that was induced by endotoxin. Elevations of amniotic fluid cytokine concentrations that were observed with endotoxin were not observed with pretreatment with betamethasone.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12592253     DOI: 10.1067/mob.2003.72

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  5 in total

1.  Association of antenatal steroid use with cord blood immune biomarkers in preterm births.

Authors:  Praveen Kumar; Scott A Venners; Lingling Fu; Colleen Pearson; Katherin Ortiz; Xiaobin Wang
Journal:  Early Hum Dev       Date:  2011-05-14       Impact factor: 2.079

2.  Effect of maternal betamethasone administration on feto-placental vascular resistance in the mouse†.

Authors:  Lindsay S Cahill; Clare L Whitehead; Sebastian R Hobson; Greg Stortz; John C Kingdom; Ahmet Baschat; Kellie E Murphy; Lena Serghides; Christopher K Macgowan; John G Sled
Journal:  Biol Reprod       Date:  2019-10-25       Impact factor: 4.285

3.  Sex differences in modulation of fetoplacental vascular resistance in growth-restricted mouse fetuses following betamethasone administration: comparisons with human fetuses.

Authors:  Lindsay S Cahill; Shiri Shinar; Clare L Whitehead; Sebastian R Hobson; Greg Stortz; Viji Ayyathurai; Anjana Ravi Chandran; Anum Rahman; John C Kingdom; Ahmet Baschat; Kellie E Murphy; Lena Serghides; Christopher K Macgowan; John G Sled
Journal:  Am J Obstet Gynecol MFM       Date:  2020-10-06

4.  Betamethasone as a potential treatment for preterm birth associated with sterile intra-amniotic inflammation: a murine study.

Authors:  Jose Galaz; Roberto Romero; Marcia Arenas-Hernandez; Bogdan Panaitescu; Robert Para; Nardhy Gomez-Lopez
Journal:  J Perinat Med       Date:  2021-04-20       Impact factor: 2.716

5.  Decidual cell FKBP51-progesterone receptor binding mediates maternal stress-induced preterm birth.

Authors:  Ozlem Guzeloglu-Kayisli; Nihan Semerci; Xiaofang Guo; Kellie Larsen; Asli Ozmen; Sefa Arlier; Duygu Mutluay; Chinedu Nwabuobi; Bradley Sipe; Irina Buhimschi; Catalin Buhimschi; Frederick Schatz; Umit A Kayisli; Charles J Lockwood
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-16       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.